Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2014 Aug 15.
Published in final edited form as: J Neurooncol. 2008 Aug 31;91(1):113–116. doi: 10.1007/s11060-008-9687-1

Sarcoidosis of the pineal gland: an unusual presentation of neurosarcoidosis

Isaac Yang 1, Amy Delpolyi 2, Michael E Sughrue 3, James Rubenstein 4, Andrew W Bollen 5, Andrew T Parsa 6,
PMCID: PMC4134350  NIHMSID: NIHMS612821  PMID: 18759061

Abstract

Introduction

Sarcoidosis is an inflammatory disease characterized by noncaseating granulomas that is rarely found as primary CNS pathology. We report an unusual case of sarcoidosis involving the pineal gland with radiographic, histopathology, and clinical data.

Case report

A 45-year-old man without evidence of systemic sarcoidosis presented with a history of gradual onset of blurry vision and diplopia that progressed over 3 months. MR imaging demonstrated an enhancing mass in the pineal region. A suboccipital craniotomy was performed with resection of the mass through a supra-cerebellar infratentorial approach. Histopathologic analysis did not reveal a pineoblastoma but instead revealed noncaseating granulomas within the pineal gland. Extensive hematologic laboratory examinations, cerebral spinal fluid studies, and cultures for infection were all negative. This mass lesion was diagnosed as solitary neurosarcoidosis of the pineal gland, without dissemination. The patient was treated with steroids and at 4-year follow-up is asymptomatic with an unremarkable MRI scan.

Conclusion

This is an unusual case of pineal sarcoidosis mimicking a tumor with associated MRI, CT and histopathologic findings reported together. Although rare, sarcoidosis of the pineal gland should not be excluded from a comprehensive differential diagnosis of an enhancing pineal region mass.

Keywords: Pineal gland, Sarcoid, Granulomatous, Inflammation, Pineoblastoma

Introduction

Sarcoidosis is an inflammatory disease of unknown etiology characterized by noncaseating granulomas, typically affecting multiple organ systems [14]. Neurosarcoidosis with central nervous system involvement is a rare condition with a poorly defined natural history, occurring in only 5–15% of sarcoidosis cases [112]. Diagnosis is difficult due to the clinical heterogeneity of the disease, particularly when systemic symptoms are not manifested [4, 5, 13].

Pineal gland tumors account for only 0.5–1% of all intracranial neoplasms in adults [14]. Most patients with a pineal region mass present with Parinaud’s syndrome, other symptoms of obstructive hydrocephalus, or cranial nerve palsies [1, 1518]. Although magnetic resonance imaging (MRI) can give initial information on the nature of the disease, a conclusive preoperative diagnosis is not possible due to the wide diversity of pineal region tumors, and hence tissue histology is critical for diagnosis of a pineal region tumor. Improvements in neuroradiology, microsurgical techniques, and neuroanesthesia have diminished the morbidity and mortality of surgical tumor removal in the pineal region [14].

Neurosarcoidosis involving the pineal gland is very rare, having only been reported three times in the literature [1, 6, 19]. Comprehensive imaging studies with CT and MRI demonstrations and concomitant associated microscopic histopathology and immunohistochemistry have not been described together in the published literature. Here we present a rare entity of neurosarcoidosis with MRI, CT and affiliated histopathologic immunohistochemistry of pineal sarcoidosis mimicking a pineoblastoma on imaging studies and review the management of neurosarcoidosis.

Case report

A 45-year-old man sought medical attention for gradual onset of blurry vision and diplopia that progressed over 3 months. These symptoms were associated with nausea, coordination difficulties, and intermittent headaches. There was no significant past medical history, no history of tumors or any previous radiation exposure. Physical exam revealed no mental status, motor, or sensory impairments, and without findings consistent with systemic sarcoidosis. The patient complained of subjective diplopia when looking down and to the right; however, extraocular movements were full with no signs of Parinaud’s syndrome and ophthalmologic exam revealed no papilledema.

Non-contrast CT imaging revealed an approximately 1 cm pineal region mass that was mildly hypodense. This lesion was embedded with apparent pineal calcifications, but heterogeneous portions of this mass were not calcified (Fig. 1). Imaging with MRI demonstrated a 1.4 × 1.8 × 1.0 cm3 mass in the pineal region. This lesion exhibited heterogeneous hypointensity on T1-weighted and prolongation on T2-weighted images, and heterogeneous contrast enhancement with gadolinium administration, without hydrocephalus (Fig. 1).

Fig. 1.

Fig. 1

(a) Non-contrast head CT revealing a 1.4-cm pineal region mass with embedded pineal calcifications. (b) MRI imaging revealing a 1.0 × 1.4 cm2 T1 hypodense lesion with heterogenous gadolinium contrast and T2 prolongation

Cerebral spinal fluid (CSF) analysis, bone marrow biopsy, and hematologic studies were negative for lymphoma and other inflammatory diseases. His work up did not indicate an immunocompromised state and he was HIV negative. Of note, his CSF angiotensin converting enzyme (ACE) was measured to be 3 U/l and serum ACE was 12 U/l neither one was elevated (UCSF reference range is 9–67 U/l). Chest, abdomen, and pelvis CT imaging revealed no other mass lesions.

A suboccipital craniotomy with a supra cerebellar infratentorial approach was performed. In the context of a patient with progressive diplopia and no diagnosis, the tissue histology is critical for diagnosis of a pineal region tumor. Intra-operatively, biopsies of the superior posterior aspect of the pineal gland were taken for frozen and permanent pathology samples. Histopathology demonstrated granulomatous inflammation with numerous well-developed compact noncaseating granulomas without associated necrosis and characteristic sarcoid morphology. Immunohistochemistry with synaptophysin, CD68, CD3, and CD20 were performed to confirm the histologic diagnosis (Fig. 2). The synaptophysin was positive in the background, indicating pineal gland tissue (Fig. 2c). No evidence of a neoplasia was identified. Thus, the histologic diagnosis was sarcoidosis of the pineal gland with typical granulomatous proliferation. Post operatively the patient underwent a short course of corticosteroids for treatment. Four years later, the patient was asymptomatic without recurrence on follow up MRI.

Fig. 2.

Fig. 2

(a) Hematoxylin and eosin staining demonstrating areas of well circumscribed, compact granulomas (100×) with (b) No necrosis within pineal gland (200×). (c) Immunohistochemistry for synaptophysin demonstrating negative granulomas within synaptophysin positive pineal gland (100×). (d) Immunohistochemistry for CD68 demonstrating well-circumscribed, non-necrotic CD68 positive granulomas within pineal gland (100×)

Discussion

Approximately 5% of all sarcoidosis cases involve the central nervous system [14, 611]. Although the meninges, cranial nerves and hypothalamus are frequently involved in neurosarcoidosis [1, 3, 4], pineal gland involvement is extremely rare, having been reported only three times in the peer-reviewed literature [1, 6, 19]. This is the first reported patient with illustrative MRI, CT, and histopathologic immunohistochemistry of pineal gland sarcoidosis with invasive characteristic on imaging mimicking a pineoblastoma.

Formation of granulomas in the central nervous system is the hallmark of neurosarcoidosis, but this characteristic is a rare finding in pineal pathology. The pathophysiology of isolated pineal sarcoidosis may be due to an autoimmune response to the unique milieu of the pineal gland. The antigens of the pineal gland may represent a unique target for the exaggerated autoimmune response resulting in pineal neurosarcoidosis. The specific etiology of sarcoidosis is unknown.

The CT imaging characteristics of neurosarcoidosis involving the pineal gland are indistinguishable from those of pineal germinomas, as sarcoids are also isodense with homogenous enhancement on CT [1, 6, 2022]. On CT imaging pineal germinomas appear isodense or mildly hyperdense with uniform contrast enhancement, typically with no calcifications other than normal pineal calcifications [1, 6, 20, 23]. Pineocytomas are typically well defined and non invasive, but our reported lesion mimicked a pineoblastoma with features of pineal tissue invasion [1, 23, 24]. The imaging characteristics of our reported pineal tumor suggested an infiltrative process suggestive of a pineoblastoma.

On MRI, neurosarcoidosis granulomas have been reported as heterogeneous masses (slightly decreased signal compared to adjacent cortical tissue on T1 weighted images) with modest gadolinium enhancement, and with hyperintense signal on T2-weighted images [1, 25, 26]. These usually consist of high intensity signals on T2 weighted images also demonstrating enhancing granulomas, meningeal involvement, paraventricular lesions, and lacunar lesions near corticomedullary junctions [22, 2530]. The difficulties in diagnosing pineal region neurosarcoidosis with MRI are confounded by the myriad of imaging characteristics associated with neurosarcoidosis [31]. An intra-axial solitary mass lesion (as reported here) is infrequent, seen in only 9% of neurosarcoidosis cases [3133]. Sarcoidosis of the pineal gland may also be interpreted with imaging characteristics similar to those of pineoblastomas as reported here in these MRI imaging findings. Neurosarcoidosis of the pineal gland is a challenging diagnosis using either CT or MR imaging.

Patients with neurosarcoidosis should be treated with corticosteroids as the mainstay of therapy [4, 34, 35]. Other anti-inflammatory agents can be used if steroids are not tolerated or contra-indicated [4, 36]. Prognosis and clinical course are best determined by clinical presentations [37, 38]. Patients exhibiting mild cranial neuropathies, aseptic meningitis, and solitary mass lesions were noted to have the best outcomes [25, 37, 38].

Our report illustrates that neurosarcoidosis should be considered in the comprehensive differential diagnosis for pineal region lesions, even if the patient has no evidence of systemic sarcoidosis. This rare presentation of sarcoidosis is amenable to steroid treatment with the expectation of good outcomes after diagnosis.

Contributor Information

Isaac Yang, Department of Neurological Surgery and Brain Tumor Research Center, University of California, San Francisco, UCSF School of Medicine, 505 Parnassus Ave. Rm. M779, San Francisco, CA 94143-0112, USA.

Amy Delpolyi, Department of Neurological Surgery and Brain Tumor Research Center, University of California, San Francisco, UCSF School of Medicine, 505 Parnassus Ave. Rm. M779, San Francisco, CA 94143-0112, USA.

Michael E. Sughrue, Department of Neurological Surgery and Brain Tumor Research Center, University of California, San Francisco, UCSF School of Medicine, 505 Parnassus Ave. Rm. M779, San Francisco, CA 94143-0112, USA

James Rubenstein, Department of Hematology and Oncology, University of California, San Francisco, UCSF School of Medicine, San Francisco, CA 94143, USA.

Andrew W. Bollen, Department of Hematology and Oncology, University of California, San Francisco, UCSF School of Medicine, San Francisco, CA 94143, USA

Andrew T. Parsa, Email: ParsaA@neurosurg.ucsf.edu, Department of Neurological Surgery and Brain Tumor Research Center, University of California, San Francisco, UCSF School of Medicine, 505 Parnassus Ave. Rm. M779, San Francisco, CA 94143-0112, USA

References

  • 1.Martin N, Debroucker T, Mompoint D, Akoun J, Cambier J, Nahum H. Sarcoidosis of the pineal region: CT and MR studies. J Comput Assist Tomogr. 1989;13:110–112. doi: 10.1097/00004728-198901000-00023. [DOI] [PubMed] [Google Scholar]
  • 2.Delaney P. Neurologic manifestations in sarcoidosis: review of the literature, with a report of 23 cases. Ann Intern Med. 1977;87:336–345. doi: 10.7326/0003-4819-87-3-336. [DOI] [PubMed] [Google Scholar]
  • 3.Nishie M, Mori F, Suzuki C, Ogawa M, Kurahashi K, Kaimori M, et al. Disseminated intraparenchymal microgranulomas in the brainstem in central nervous system sarcoidosis. Neuropathology. 2005;25:361–364. doi: 10.1111/j.1440-1789.2005.00623.x. [DOI] [PubMed] [Google Scholar]
  • 4.Hoitsma E, Faber CG, Drent M, Sharma OP. Neurosarcoidosis: a clinical dilemma. Lancet Neurol. 2004;3:397–407. doi: 10.1016/S1474-4422(04)00805-1. [DOI] [PubMed] [Google Scholar]
  • 5.Mahadewa TG, Nakagawa H, Watabe T, Inoue T. Intramedullary neurosarcoidosis in the medulla oblongata: a case report. Surg Neurol. 2004;61:283–287. doi: 10.1016/S0090-3019(03)00398-7. discussion 287. [DOI] [PubMed] [Google Scholar]
  • 6.Wall MJ, Peyster RG, Finkelstein SD, Pistone WR, Hoover ED. A unique case of neurosarcoidosis with pineal and suprasellar involvement: CT and pathological demonstration. J Comput Assist Tomogr. 1985;9:381–383. doi: 10.1097/00004728-198503000-00032. [DOI] [PubMed] [Google Scholar]
  • 7.Aszkanazy CL. Sarcoidosis of the central nervous system. J Neuropathol Exp Neurol. 1952;11:392–400. doi: 10.1097/00005072-195210000-00003. [DOI] [PubMed] [Google Scholar]
  • 8.Camp WA, Frierson JG. Sarcoidosis of the central nervous system. A case with postmortem studies. Arch Neurol. 1962;7:432–441. doi: 10.1001/archneur.1962.04210050068008. [DOI] [PubMed] [Google Scholar]
  • 9.Wiederholt WC, Siekert RG. Neurological manifestations of sarcoidosis. Neurology. 1965;15:1147–1154. doi: 10.1212/wnl.15.12.1147. [DOI] [PubMed] [Google Scholar]
  • 10.Stern BJ. Neurological complications of sarcoidosis. Curr Opin Neurol. 2004;17:311–316. doi: 10.1097/00019052-200406000-00013. [DOI] [PubMed] [Google Scholar]
  • 11.Gullapalli D, Phillips LH., 2nd Neurologic manifestations of sarcoidosis. Neurol Clin. 2002;20:59–83. vi. doi: 10.1016/s0733-8619(03)00054-9. [DOI] [PubMed] [Google Scholar]
  • 12.Ferriby D, de Seze J, Stojkovic T, Hachulla E, Wallaert B, Destee A, et al. Long-term follow-up of neurosarcoidosis. Neurology. 2001;57:927–929. doi: 10.1212/wnl.57.5.927. [DOI] [PubMed] [Google Scholar]
  • 13.Kidd D, Beynon HL. The neurological complications of systemic sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 2003;20:85–94. [PubMed] [Google Scholar]
  • 14.Konovalov AN, Pitskhelauri DI. Principles of treatment of the pineal region tumors. Surg Neurol. 2003;59:250–268. doi: 10.1016/S0090-3019(03)00223-4. [DOI] [PubMed] [Google Scholar]
  • 15.Healton EB, Zito G, Chauhan P, Brust JC. Intracranial subdural sarcoid granuloma. Case report. J Neurosurg. 1982;56:728–731. doi: 10.3171/jns.1982.56.5.0728. [DOI] [PubMed] [Google Scholar]
  • 16.Fetell MR, Bruce JN, Burke AM, Cross DT, Torres RA, Powers JM, et al. Non-neoplastic pineal cysts. Neurology. 1991;41:1034–1040. doi: 10.1212/wnl.41.7.1034. [DOI] [PubMed] [Google Scholar]
  • 17.Bruce JN, Stein BM. Pineal tumors. Neurosurg Clin N Am. 1990;1:123–138. [PubMed] [Google Scholar]
  • 18.Stein BM, Bruce JN. Surgical management of pineal region tumors (honored guest lecture) Clin Neurosurg. 1992;39:509–532. [PubMed] [Google Scholar]
  • 19.Schaeffer M, Lapras C, Thomalske G, Grau H, Schober R. Sarcoidosis of the pineal gland. Case report. J Neurosurg. 1977;47:630–632. doi: 10.3171/jns.1977.47.4.0630. [DOI] [PubMed] [Google Scholar]
  • 20.Ganti SR, Hilal SK, Stein BM, Silver AJ, Mawad M, Sane P. CT of pineal region tumors. AJR Am J Roentgenol. 1986;146:451–458. doi: 10.2214/ajr.146.3.451. [DOI] [PubMed] [Google Scholar]
  • 21.Futrell NN, Osborn AG, Cheson BD. Pineal region tumors: computed tomographic-pathologic spectrum. AJR Am J Roentgenol. 1981;137:951–956. doi: 10.2214/ajr.137.5.951. [DOI] [PubMed] [Google Scholar]
  • 22.Hayes WS, Sherman JL, Stern BJ, Citrin CM, Pulaski PD. MR and CT evaluation of intracranial sarcoidosis. AJR Am J Roentgenol. 1987;149:1043–1049. doi: 10.2214/ajr.149.5.1043. [DOI] [PubMed] [Google Scholar]
  • 23.Reis F, Faria AV, Zanardi VA, Menezes JR, Cendes F, Queiroz LS. Neuroimaging in pineal tumors. J Neuroimaging. 2006;16:52–58. doi: 10.1177/1051228405001514. [DOI] [PubMed] [Google Scholar]
  • 24.Cuccia V, Rodriguez F, Palma F, Zuccaro G. Pinealoblastomas in children. Childs Nerv Syst. 2006;22:577–585. doi: 10.1007/s00381-006-0095-6. [DOI] [PubMed] [Google Scholar]
  • 25.Sponsler JL, Werz MA, Maciunas R, Cohen M. Neurosarcoidosis presenting with simple partial seizures and solitary enhancing mass: case reports and review of the literature. Epilepsy Behav. 2005;6:623–630. doi: 10.1016/j.yebeh.2005.02.016. [DOI] [PubMed] [Google Scholar]
  • 26.Christoforidis GA, Spickler EM, Recio MV, Mehta BM. MR of CNS sarcoidosis: correlation of imaging features to clinical symptoms and response to treatment. AJNR Am J Neuroradiol. 1999;20:655–669. [PMC free article] [PubMed] [Google Scholar]
  • 27.Lexa FJ, Grossman RI. MR of sarcoidosis in the head and spine: spectrum of manifestations and radiographic response to steroid therapy. AJNR Am J Neuroradiol. 1994;15:973–982. [PMC free article] [PubMed] [Google Scholar]
  • 28.Miller DH, Kendall BE, Barter S, Johnson G, MacManus DG, Logsdail SJ, et al. Magnetic resonance imaging in central nervous system sarcoidosis. Neurology. 1988;38:378–383. doi: 10.1212/wnl.38.3.378. [DOI] [PubMed] [Google Scholar]
  • 29.Scott TF. Neurosarcoidosis: progress and clinical aspects. Neurology. 1993;43:8–12. doi: 10.1212/wnl.43.1_part_1.8. [DOI] [PubMed] [Google Scholar]
  • 30.Dumas JL, Valeyre D, Chapelon-Abric C, Belin C, Piette JC, Tandjaoui-Lambiotte H, et al. Central nervous system sarcoidosis: follow-up at MR imaging during steroid therapy. Radiology. 2000;214:411–420. doi: 10.1148/radiology.214.2.r00fe05411. [DOI] [PubMed] [Google Scholar]
  • 31.Pickuth D, Spielmann RP, Heywang-Kobrunner SH. Role of radiology in the diagnosis of neurosarcoidosis. Eur Radiol. 2000;10:941–944. doi: 10.1007/s003300051042. [DOI] [PubMed] [Google Scholar]
  • 32.Pickuth D, Heywang-Kobrunner SH. Neurosarcoidosis: evaluation with MRI. J Neuroradiol. 2000;27:185–188. [PubMed] [Google Scholar]
  • 33.Fels C, Riegel A, Javaheripour-Otto K, Obenauer S. Neurosarcoidosis: findings in MRI. Clin Imaging. 2004;28:166–169. doi: 10.1016/S0899-7071(03)00146-3. [DOI] [PubMed] [Google Scholar]
  • 34.Modi M, Bhatia R, Jain R, Lal V, Radotra BD, Aggarwal A. Uncommon manifestations of neurosarcoidosis. Neurol India. 2004;52:280–281. [PubMed] [Google Scholar]
  • 35.Hunninghake GW, Gilbert S, Pueringer R, Dayton C, Floerchinger C, Helmers R, et al. Outcome of the treatment for sarcoidosis. Am J Respir Crit Care Med. 1994;149:893–898. doi: 10.1164/ajrccm.149.4.8143052. [DOI] [PubMed] [Google Scholar]
  • 36.Sharma OP. Effectiveness of chloroquine and hydroxychloroquine in treating selected patients with sarcoidosis with neurological involvement. Arch Neurol. 1998;55:1248–1254. doi: 10.1001/archneur.55.9.1248. [DOI] [PubMed] [Google Scholar]
  • 37.Oksanen V. Neurosarcoidosis: clinical presentations and course in 50 patients. Acta Neurol Scand. 1986;73:283–290. doi: 10.1111/j.1600-0404.1986.tb03277.x. [DOI] [PubMed] [Google Scholar]
  • 38.Chapelon C, Ziza JM, Piette JC, Levy Y, Raguin G, Wechsler B, et al. Neurosarcoidosis: signs, course and treatment in 35 confirmed cases. Medicine (Baltimore) 1990;69:261–276. doi: 10.1097/00005792-199009000-00001. [DOI] [PubMed] [Google Scholar]

RESOURCES